Report from Gambro's Annual General Meeting, March 25, 2002

Report from Gambro's Annual General Meeting, March 25, 2002 Stockholm, Sweden, March 26, 2002 Gambro AB (Stockholmsbörsen: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, reports the following decisions taken at the Annual General Meeting. Board of Directors Claes Dahlbäck, Sandra Austin Crayton, Gösta Gahrton, Wilbur H Gantz, Peter H Grassmann, Juha P Kokko, Sören Mellstig, Håkan Mogren and Björn Svedberg were reelected members of the Board. Sven Nyman had declined reelection. At the statutory Board meeting following the Annual General Meeting, Claes Dahlbäck was elected Chairman and Håkan Mogren was elected Vice Chairman. Dividend The Meeting approved a dividend for 2001 of SEK 1.10 per share, with a record date of March 28, 2002. With this record date, dividends are expected to be paid from VPC (The Swedish Central Securities Depository and Clearing Organisation) on April 4, 2002. Purchase and sale of the Company's own shares The proposed authority for the Board to decide on the purchase and sale of the Company's own shares was approved. In short this includes authority for the Board to decide on the acquisition of own shares subject to certain conditions as well as authority to dispose of own shares subject to certain conditions. For further information please contact: Karin Avasalu, Vice President, Corporate Communications, tel. +46-8-613 65 99, +46-70-513 65 99 Pia Irell, Investor Relations Director, Corporate Finance, tel. +46-8-613 65 91, +46-70-513 65 91 Kevin Smith, President Gambro Inc., Investor Relations US, tel. +1-303 231 4750 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/03/26/20020326BIT00020/wkr0001.doc http://www.waymaker.net/bitonline/2002/03/26/20020326BIT00020/wkr0002.pdf